SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp (ESHA) is trending amidst a broader "SPAC mania," with community discussion centered on its exceptionally low public float and high insider ownership. Traders are actively comparing it to recent explosive movers like AFJK, believing ESHA's tight share structure positions it for significant, rapid gains. This setup is fueling speculative interest and discussions around its potential for sharp upward price action.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) is trending due to the FDA approval of NEREUS, which marks the first new pharmacologic treatment for motion sickness in over four decades and is seen by many as significantly under-modeled by the market. The community is actively discussing its potential for off-label use in addressing GLP-1 induced nausea, positioning it as a major upside driver with billions in market potential and fueling significant speculation about a potential buyout from a larger GL-1 focused pharmaceutical company. This approval, coupled with other pipeline catalysts, signals a significant re-rating opportunity for VNDA as it transitions into a commercial-stage company.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending sharply lower after receiving a Complete Response Letter from the FDA for its relacorilant drug, intended for Cushing's syndrome. The community is actively debating the severe market reaction, with many expressing disappointment and predicting further downside, while others view the significant dip as a potential buying opportunity. This decision casts a shadow on the company's near-term growth strategy and future pipeline utilizing similar mechanisms, prompting discussions around its market valuation relative to existing revenue and competitors.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending amid news of a new manufacturing partnership aimed at boosting production and margins, coupled with persistent community focus on its ongoing FDA 510(k) clearance process for a non-invasive fingerprint drug screening system. Investors are keenly anticipating the potential for significant upside from U.S. market entry, driven by the technology's innovation and the stock's low float, though concerns around potential dilution and extended FDA timelines continue to spark debate.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology ($AFJK) is currently a prime focus for event-driven traders due to its low float and ongoing speculation around potential business combination news, fueling significant volatility. The community is actively discussing its potential for short squeezes and its resemblance to other recent high-flying SPACs in a speculative market.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is gaining significant attention following the FDA's acceptance and priority review of its supplemental New Drug Application for AXS-05 for Alzheimer's agitation. This expedited regulatory pathway is sparking considerable investor excitement, with the community highly optimistic about the company's expanding central nervous system pipeline and the continued strong commercial performance of its existing therapies.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as a key competitor, Corcept Therapeutics, faced an FDA Complete Response Letter for its Cushing's syndrome treatment, effectively clearing the path for Xeris's rapidly growing Recorlev to capture more market share. The community is buzzing with enthusiasm, emphasizing Xeris's strong gross margins, anticipated profitability, and the multi-blockbuster potential of its XP-8121 pipeline, leading to widespread expectations for a significant re-rating by analysts.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as China extends crucial EV trade-in subsidies into 2026, coinciding with the CEO's upbeat Q4 sales forecast and recent rapid delivery milestones for its ES8 model. The community is sharply divided, with bulls anticipating a significant short squeeze and potential profitability driven by NIO's unique battery swap ecosystem, while others remain skeptical about sustained gains despite these positive developments.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corporation (BULL) is actively trending as investors discuss significant year-end tax loss harvesting contributing to recent price declines. Community sentiment is sharply divided, with optimists highlighting the fintech brokerage's profitability, growing user base, and international expansion as a long-term opportunity, while skeptics warn of persistent dilution and fierce competition.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Blockchain Inc

Riot Platforms is trending due to a new stock offering, sparking community debate about potential dilution and its impact on share value. Many investors are vocalizing concerns, with some labeling it a "share selling scam" and noting the stock's struggle to align with broader cryptocurrency market trends. Amidst this, there's ongoing discussion about the company's potential to secure AI/datacenter contracts to leverage its energy capacity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Filings showed that Bitwise filed 11 crypto-related ETF applications to the U.S. Securities and Exchange Commission (SEC) on Tuesday.</li><li>Grayscale also moved to convert its Bittensor Trust into a publicly traded ETF on NYSE Arca.</li><li>Grayscale forecasted a bullish 2026 for crypto ETFs, driven by institutional adoption and regulatory clarity.</li></ul><p>The U.S. ETF market saw a wave of late-year activity, with Bitwise filing 11 crypto ETFs, Grayscale moving to convert its Bittensor Trust, and Trump Media (DJT) launching five themed funds.</p><h2 class="st-heading-2">Bitwise Files 11 Crypto ETF Proposals</h2><p>Filings showed that Bitwise filed 11 crypto-related ETF applications to the U.S. Securities and Exchange Commission (SEC) on Tuesday, targeting a range of assets including Aave (AAVE), Uniswap (UNI), Zcash (ZEC), Ethena (ENA), Hyperliquid (HYPE), Near (NEAR), Starknet (STRK), Sui (SUI), Bittensor (TAO), and Tron (TRON).</p><p>The proposals reflect confidence that demand for crypto exposure beyond Bitcoin (BTC) and Ethereum (ETH) is expected to expand ahead of the CLARITY Act and other crypto regulations are slated for passage in 2026. Several of the proposed ETFs focus on decentralized finance (DeFi) and AI-linked tokens, highlighting investor appetite for themes beyond the two largest cryptocurrencies – Bitcoin (BTC) and Ethereum (ETH).</p><h2 class="st-heading-2">Bitwise Isn’t The Only One Eyeing Altcoins</h2><p>Even Arthur Hayes, the chief investment officer and co-founder of Maelstrom, has been selling&nbsp;off Ethereum to buy more DeFi tokens such as Ethena.</p><p><a href="https://stocktwits.com/coins/ethena">ENA’s price</a> edged 0.3% higher on Tuesday night to around $0.2044. Retail sentiment around the token on Stocktwits rose to ‘bullish’ from ‘neutral’ territory over the past day.</p><p>If Grayscale’s ETFs are approved, the lineup would represent one of the broadest pushes yet for single-asset crypto ETFs tied to emerging blockchain ecosystems.</p><p>Zcash, also on Bitwise’s list,&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/zcash-emerges-as-q4-outperformer-while-bitcoin-ethereum-lost-ground/cL74Y8RREUc">outperformed</a> the broader crypto market and led gains among privacy-based coins in the fourth quarter (Q4) of 2025.&nbsp;<a href="https://stocktwits.com/coins/zcash">ZEC’s price</a> fell 1.43% in the last 24 hours, with retail sentiment around the token on Stocktwits in ‘bullish’ territory over the past day, accompanied by ‘high’ levels of chatter.</p><h2 class="st-heading-2">Grayscale Moves To Convert Bittensor Trust</h2><p>Grayscale also advanced its ETF ambitions by filing a Form S-1 to convert its&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/grayscale-s-bittensor-etf-makes-public-debut-fails-to-lift-token-price-amid-crypto-market-slump/cLIxXECREnV">Grayscale Bittensor Trust</a> into an ETF. The product would be renamed the Grayscale Bittensor Trust ETF and listed on NYSE Arca.</p><p>The move follows Grayscale’s broader strategy to transition its trust products into ETFs, as it did with Bitcoin, Ethereum and Solana (SOL) trusts as well. A Bittensor ETF would give investors regulated exposure to the AI-focused blockchain network without direct token custody.</p><h2 class="st-heading-2">Leveraged And Thematic ETFs Gain Ground</h2><p>Issuers are also leaning into higher-risk strategies tied to crypto-linked equities. Defiance launched the Defiance Daily Target 2X Long BITF ETF, a leveraged product designed to deliver twice the daily performance of Bitfarms (BITF) stock.</p><p><a href="https://stocktwits.com/symbol/BITF">BITF’s stock</a> edged 0.84% lower in after-hours trade on Tuesday after dropping 3.25% in regular trading. Retail sentiment around the company remained in ‘extremely bearish’ territory over the past day.&nbsp;</p><p>Separately, Trump Media announced the launch of five Truth Social-branded ETFs on the NYSE, including funds focused on defense, energy, technology, and real estate. The products include American Security &amp; Defense (TSSD), American Next Frontiers (TSFN), American Icons (TSIC), American Energy Security (TSES), and American Red State REITs (TSRS).&nbsp;</p><p><a href="https://stocktwits.com/symbol/DJT/">DJT’s stock</a> moved 0.24% lower in after-hours trade on Tuesday after falling 4.48% in regular trading hours. Retail sentiment around the Trump-backed enterprise remained in ‘bearish’ territory over the past day.&nbsp;</p><h2 class="st-heading-2">A Broader ETF Playbook Heading Into 2026</h2><p>Grayscale forecasted a bullish 2026 for crypto ETFs, driven by institutional adoption and regulatory clarity, with Bitcoin potentially hitting new highs in the first half of the year. They predict expanded ETF availability for assets like Solana (SOL), XRP (XRP), Dogecoin (DOGE), and Chainlink (LINK), including staking features to attract yield-seeking investors. Other firms like Standard Chartered align, eyeing Bitcoin at $150,000 by end-2026 amid steady institutional inflows.</p><p>Bitcoin’s price rose 1.4% in the last 24 hours to around $88,300 on Tuesday night. The apex cryptocurrency is on track to&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-on-track-to-end-first-ever-post-halving-year-in-the-red/cL74zJfREUZ">end its post-halving year in the red</a> for the first time ever. On Stocktwits, retail sentiment around BTC remained in ‘bearish’ territory over the past day.</p><p><strong>Read also:&nbsp;</strong><a href="https://stocktwits.com/news-articles/markets/cryptocurrency/bitcoin-on-track-to-end-first-ever-post-halving-year-in-the-red/cL74zJfREUZ"><strong>Bitcoin Has Never Ended A Post-Halving Year In The Red — And BTC’s Down 7% With Days To Go</strong></a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the Bitwise logo is seen on a smartphone and in the background. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Bitwise, Grayscale, Trump Media Lead Wall Street’s Year-End ETF Frenzy

Bitwise filed 11 crypto ETF proposals on Tuesday covering DeFi, AI-linked, and emerging blockchain assets.

Cryptocurrency

Bitwise filed 11 crypto ETF proposals on Tuesday covering DeFi, AI-linked, and emerging blockchain assets.


Promising Cryptocurrency Stocks To Watch Now - December 30th

Bitfarms, Galaxy Digital, and Digi Power X are the three Cryptocurrency stocks to watch today, according to MarketBeat's stock screener tool. "Cryptocurrency stocks" are shares of publicly traded...

Cryptocurrency Stocks To Consider - December 29th

Bitfarms, Galaxy Digital, HIVE Digital Technologies, Digi Power X, Soluna, ZenaTech, and Bit Origin are the seven Cryptocurrency stocks to watch today, according to MarketBeat's stock screener tool...

Bitfarms (NASDAQ:BITF) Trading Up 3.4% - Time to Buy?

Bitfarms (NASDAQ:BITF) Stock Price Up 3.4% - Should You Buy...

Bitfarms vs. Robinhood: The Better Growth Story

Key PointsInvestors are pricing in aggressive earnings growth for Bitfarms in 2026...

Cryptocurrency Stocks To Watch Now - December 28th

Galaxy Digital, Bitfarms, HIVE Digital Technologies, Digi Power X, and Soluna are the five Cryptocurrency stocks to watch today, according to MarketBeat's stock screener tool. "Cryptocurrency stocks...

832,985 Shares in Bitfarms Ltd. $BITF Bought by Voya Investment Management LLC

Voya Investment Management LLC acquired a new stake in shares of Bitfarms Ltd. (NASDAQ:BITF - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the...

Cryptocurrency Stocks To Follow Today - December 27th

Galaxy Digital, Bitfarms, and HIVE Digital Technologies are the three Cryptocurrency stocks to watch today, according to MarketBeat's stock screener tool. "Cryptocurrency stocks" are shares of...

Best Cryptocurrency Stocks Worth Watching - December 26th

Bitfarms, Galaxy Digital, HIVE Digital Technologies, Digi Power X, and ZenaTech are the five Cryptocurrency stocks to watch today, according to MarketBeat's stock screener tool. Cryptocurrency stocks...

Bitfarms (NASDAQ:BITF) Trading Down 5.1% - Here's What Happened

Bitfarms (NASDAQ:BITF) Trading Down 5.1% - What's Next...

Bitfarms Ltd. (Canada) engages in the business of mining cryptocurrency. The firm is also involved in the ownership and operation of server farms comprised of computers designed for the purpose of validating transactions on the Bitcoin blockchain. The company was founded by Emiliano Joel Grodzki and Nicolas Bonta in 2017 and is headquartered in Toronto, Canada.

BITF
Bitfarms Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BITF News

BITFBitfarms Ltd.